Chlorothiazide

The dosage of Chlorothiazide is highly individualized based on the patient's response and the condition being treated. According to clinical guidelines, the goal is to achieve the maximum therapeutic effect with the lowest possible dose.

• For Edema: The typical adult starting dose is 500 mg to 1000 mg once or twice daily. Some patients may respond to intermittent therapy (taking the dose every other day or 3 to 5 days per week) to reduce the risk of electrolyte imbalances.
• For Hypertension: The usual adult starting dose is 125 mg to 500 mg daily, administered as a single dose or divided into two doses. It is rare to exceed 1000 mg per day for hypertension, as higher doses often increase side effects without providing additional blood pressure lowering.

Chlorothiazide is one of the few thiazide diuretics with well-established pediatric dosing guidelines, often utilized in the neonatal intensive care unit (NICU) or for children with congenital heart defects.

• Infants and Children: The standard dosage is 10 mg to 20 mg per kilogram (mg/kg) of body weight per day, administered in a single dose or two divided doses.
• Infants under 6 months: May require up to 30 mg/kg per day in two divided doses to achieve adequate diuresis.
• Maximum Dose: Pediatric dosing should generally not exceed 375 mg per day for infants up to 2 years of age, or 1000 mg per day for older children.

Renal Impairment

Chlorothiazide loses its efficacy as kidney function declines. In patients with a creatinine clearance (CrCl) of less than 30 mL/min, thiazide diuretics are generally considered ineffective. In such cases, "loop diuretics" (like furosemide) are usually preferred. If used in patients with mild renal impairment, frequent monitoring of BUN and creatinine is required.

Hepatic Impairment

Use with extreme caution in patients with impaired hepatic function or progressive liver disease. Minor alterations of fluid and electrolyte balance may precipitate hepatic coma (a loss of brain function due to liver failure).

Elderly Patients

Older adults should generally start at the lower end of the dosing range (e.g., 125 mg for hypertension). The elderly are more susceptible to dehydration, orthostatic hypotension (dizziness upon standing), and electrolyte depletion. Clinical data suggests that lower doses are often sufficient for blood pressure control in this population.

• Timing: It is strongly recommended to take Chlorothiazide in the morning. Because it increases urination, taking it late in the evening may lead to nocturia (waking up during the night to urinate), which can disrupt sleep.
• With or Without Food: You may take this medication with food if it causes stomach upset, but consistency is key. Try to take it the same way every day.
• Liquid Form: If using the oral suspension, shake the bottle well before each dose and use a calibrated measuring device (not a household spoon) to ensure accuracy.
• Storage: Store at room temperature (20°C to 25°C / 68°F to 77°F) away from excessive heat and moisture.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of dehydration and electrolyte disturbances.

Signs of a Chlorothiazide overdose primarily relate to excessive loss of fluid and electrolytes. Symptoms may include:

• Extreme thirst and dry mouth
• Muscle cramps or weakness
• Severe dizziness or fainting
• Confusion and lethargy
• Heart palpitations (arrhythmias)
• Nausea and vomiting

In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is generally supportive, focusing on replacing fluids and correcting electrolyte imbalances.

> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without medical guidance, as sudden changes can cause your blood pressure to spike or fluid to return rapidly.

Most patients tolerate Chlorothiazide well, but because it alters the body's chemistry, some side effects are common. These are often dose-related and may improve as the body adjusts to the medication.

• Dizziness and Lightheadedness: Especially when rising from a sitting or lying position. This is due to the reduction in blood volume.
• Headache: Often occurring in the first few days of therapy.
• Increased Urination: This is the intended effect of the drug but can be bothersome for some patients.
• Stomach Upset: Including mild nausea or cramping.
• Fatigue: A general feeling of tiredness as the body adapts to lower blood pressure.

• Photosensitivity: Your skin may become more sensitive to sunlight, leading to easier sunburns or rashes. It is advised to use sunscreen and wear protective clothing.
• Hyperglycemia: An increase in blood sugar levels. This is particularly important for patients with diabetes to monitor.
• Hyperuricemia: An increase in uric acid levels in the blood, which may trigger a gout attack in susceptible individuals.
• Orthostatic Hypotension: A significant drop in blood pressure upon standing that may cause brief fainting (syncope).

• Agranulocytosis: A dangerous drop in white blood cell count, increasing the risk of infection.
• Aplastic Anemia: A condition where the body stops producing enough new blood cells.
• Pancreatitis: Inflammation of the pancreas, characterized by severe abdominal pain radiating to the back.
• Necrotizing Angiitis: Inflammation of the blood vessels (vasculitis).
• Toxic Epidermal Necrolysis: A severe, life-threatening skin reaction.

> Warning: Stop taking Chlorothiazide and call your doctor immediately if you experience any of these symptoms, which may indicate a severe electrolyte imbalance or allergic reaction.

1. 1Hypokalemia (Low Potassium): Symptoms include muscle weakness, irregular heartbeats, intense leg cramps, and a "fluttering" feeling in the chest.
2. 2Hyponatremia (Low Sodium): Symptoms include confusion, seizures, severe headache, and extreme lack of energy. This can be life-threatening if not addressed.
3. 3Hypomagnesemia (Low Magnesium): Symptoms include tremors, jerky movements, and abnormal heart rhythms.
4. 4Allergic Reaction (Anaphylaxis): Signs include hives, difficulty breathing, and swelling of the face, lips, tongue, or throat.
5. 5Jaundice: Yellowing of the skin or the whites of the eyes, which may indicate liver distress.
6. 6Acute Myopia and Secondary Angle-Closure Glaucoma: Sudden decrease in vision or eye pain. This is a rare but emergency reaction to sulfonamide-derived drugs like Chlorothiazide.

Prolonged use of Chlorothiazide requires ongoing medical supervision. Long-term effects can include:

• Metabolic Alkalosis: A condition where the body's pH becomes too alkaline due to the loss of chloride and hydrogen ions.
• Changes in Cholesterol: Some studies suggest that thiazides may cause small, transient increases in LDL (bad cholesterol) and triglycerides.
• Chronic Kidney Stress: While used to treat kidney-related edema, long-term diuretic use requires monitoring to ensure the kidneys are not being overworked or dehydrated.
• Sexual Dysfunction: Some male patients report difficulty achieving or maintaining an erection while on thiazide therapy.

No FDA black box warnings for Chlorothiazide. Unlike some more potent diuretics, Chlorothiazide does not carry a boxed warning, but its potential for profound diuresis and electrolyte depletion is considered a major clinical precaution.

Report any unusual symptoms to your healthcare provider. Regular blood tests are essential to catch side effects before they become serious.

Chlorothiazide is a potent medication that requires careful monitoring. Patients must be aware that while it treats the symptoms of high blood pressure and edema, it does not "cure" these conditions. Therapy is often lifelong. The most critical safety concern is the maintenance of fluid and electrolyte balance. Dehydration and mineral loss can occur rapidly, especially during hot weather, bouts of vomiting or diarrhea, or periods of intense exercise.

As of 2026, there are no FDA black box warnings for Chlorothiazide. However, the FDA emphasizes that this drug should be used only after a thorough clinical assessment of the patient's renal and hepatic status.

• Sulfonamide Allergy: Chlorothiazide is a sulfonamide derivative. Patients with a known allergy to "sulfa drugs" (such as Bactrim or certain diabetes medications) may experience a cross-allergic reaction. Symptoms can range from mild rashes to life-threatening skin conditions.
• Systemic Lupus Erythematosus: Thiazide diuretics have been reported to activate or exacerbate systemic lupus erythematosus. If you have an autoimmune condition, discuss this with your doctor.
• Diabetes Mellitus: Chlorothiazide can raise blood glucose levels. Patients with diabetes may need adjustments to their insulin or oral hypoglycemic medications.
• Gout: By increasing uric acid levels, Chlorothiazide can precipitate an acute gouty attack. Patients with a history of gout should be monitored closely.
• Renal Function: In patients with progressive renal disease, the drug may increase azotemia (buildup of nitrogenous waste in the blood). If renal impairment worsens, the doctor may discontinue the drug.

Your healthcare provider will schedule regular laboratory tests to ensure the medication is working safely. These typically include:

• Serum Electrolytes: Checking levels of potassium, sodium, chloride, and bicarbonate. This is usually done within the first 2 weeks of starting therapy and periodically thereafter.
• Renal Function Tests: Measuring Blood Urea Nitrogen (BUN) and Serum Creatinine to ensure the kidneys are handling the fluid changes.
• Blood Glucose: Monitoring for new-onset hyperglycemia.
• Uric Acid Levels: Especially for those with a history of gout.
• Blood Pressure: Home monitoring is often encouraged to track the drug's effectiveness.

Chlorothiazide can cause dizziness, blurred vision, or lightheadedness, particularly during the first few days of treatment or when the dose is increased. Do not drive, operate heavy machinery, or engage in dangerous activities until you know how this medication affects you. If you feel faint, sit or lie down immediately.

Alcohol consumption should be limited while taking Chlorothiazide. Alcohol can enhance the blood pressure-lowering effect of the drug, significantly increasing the risk of orthostatic hypotension (severe dizziness upon standing). This can lead to falls and injuries.

Do not stop taking Chlorothiazide abruptly. For patients with hypertension, stopping the medication can lead to a "rebound" effect where blood pressure rises rapidly. For patients with heart failure, stopping the drug can cause a sudden buildup of fluid in the lungs (pulmonary edema), which is a medical emergency. If the drug must be stopped, your doctor will provide a tapering schedule.

> Important: Discuss all your medical conditions, especially kidney disease, liver disease, and diabetes, with your healthcare provider before starting Chlorothiazide.

• Dofetilide: Using Chlorothiazide with dofetilide (an anti-arrhythmic) is generally contraindicated. Thiazides can cause low potassium or magnesium, which increases the risk of dofetilide-induced Torsades de Pointes, a life-threatening heart rhythm disorder.

• Lithium: Chlorothiazide reduces the renal clearance of lithium. When the body loses sodium due to the diuretic, the kidneys "mistake" lithium for sodium and reabsorb it back into the blood. This can lead to toxic levels of lithium, characterized by tremors, confusion, and kidney damage.
• Digoxin: Low potassium levels (hypokalemia) caused by Chlorothiazide significantly increase the risk of digitalis toxicity. This can lead to dangerous heart arrhythmias.
• NSAIDs (e.g., Ibuprofen, Naproxen): Nonsteroidal anti-inflammatory drugs can reduce the diuretic and antihypertensive effects of Chlorothiazide. Furthermore, the combination can place significant strain on the kidneys, potentially leading to acute renal failure.

• Corticosteroids (e.g., Prednisone): These medications can worsen the loss of potassium, leading to severe hypokalemia.
• Antidiabetic Drugs: Chlorothiazide may reduce the effectiveness of insulin or oral diabetes medications, requiring a dose adjustment of the diabetes treatment.
• Other Antihypertensives: While often used together, the combination with ACE inhibitors or Beta-blockers can cause an additive effect, leading to excessively low blood pressure.
• Cholestyramine and Colestipol: These bile acid sequestrants can bind to Chlorothiazide in the gut, reducing its absorption. Chlorothiazide should be taken at least 1 hour before or 4 hours after these medications.

• Licorice: Natural black licorice contains glycyrrhizic acid, which can cause the body to lose potassium. Combining this with Chlorothiazide can lead to dangerously low potassium levels.
• High-Sodium Foods: Consuming excessive salt can counteract the diuretic effect of the medication, making it less effective at reducing fluid and lowering blood pressure.
• Calcium Supplements: Thiazides reduce the excretion of calcium. Taking large amounts of calcium supplements or antacids containing calcium (like Tums) could lead to hypercalcemia (excessively high blood levels of calcium).

• St. John's Wort: May increase the risk of photosensitivity (sun sensitivity) when combined with Chlorothiazide.
• Ginkgo Biloba: Some studies suggest it may interfere with blood pressure regulation.
• Dandelion: Acts as a natural diuretic and may increase the risk of dehydration if taken alongside Chlorothiazide.

Chlorothiazide can interfere with several diagnostic tests:

• Parathyroid Function Tests: Because thiazides affect calcium excretion, they should be discontinued before carrying out tests for parathyroid function.
• Protein-Bound Iodine (PBI): Thiazides may decrease serum PBI levels without indicating thyroid dysfunction.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list helps prevent dangerous interactions.

There are specific circumstances where Chlorothiazide must NEVER be used because the risks far outweigh any potential benefits:

1. 1Anuria: This is a condition where the kidneys are not producing urine (usually defined as less than 100mL per day). If the kidneys cannot produce urine, a diuretic has no site of action and will only accumulate to toxic levels in the blood.
2. 2Hypersensitivity to Chlorothiazide or Sulfonamides: If a patient has had a previous severe allergic reaction (anaphylaxis, Stevens-Johnson Syndrome) to Chlorothiazide or any sulfa-based medication, the drug is strictly forbidden. The molecular structure of Chlorothiazide contains a sulfonamide moiety, which is the site of cross-reactivity.

In these situations, a healthcare provider will perform a careful risk-benefit analysis and may choose an alternative medication:

• Severe Electrolyte Depletion: If a patient already has significantly low levels of potassium, sodium, or chloride, starting Chlorothiazide can push these levels into a life-threatening range.
• Severe Renal Failure: When the creatinine clearance is below 30 mL/min, the drug is unlikely to be effective and may increase the risk of side effects.
• Hepatic Encephalopathy: In patients with severe liver cirrhosis who are already showing signs of brain dysfunction (confusion, tremors), the electrolyte shifts caused by Chlorothiazide can worsen the condition or trigger a coma.
• Pregnancy-Induced Hypertension: While thiazides are used for chronic hypertension, they are generally avoided in pregnancy-induced hypertension (preeclampsia) because they do not prevent the progression of the disease and may reduce placental perfusion.

Patients should be aware of cross-sensitivity with other drugs. If you have had a reaction to the following, you may be at risk when taking Chlorothiazide:

• Loop Diuretics (like Furosemide or Bumetanide)
• Carbonic Anhydrase Inhibitors (like Acetazolamide)
• Sulfonylureas (oral diabetes drugs like Glipizide)
• Sulfonamide Antibiotics

> Important: Your healthcare provider will evaluate your complete medical history, including all past allergies and kidney function tests, before prescribing Chlorothiazide.

Chlorothiazide is categorized by the FDA as Pregnancy Category C. This means that animal reproduction studies have shown an adverse effect on the fetus, and there are no adequate and well-controlled studies in humans.

• Risks: Thiazides cross the placental barrier and appear in cord blood. Use during pregnancy carries the risk of fetal or neonatal jaundice, thrombocytopenia (low platelet count), and possibly other adverse reactions that have occurred in adults.
• Clinical Use: It is generally not used to treat the normal swelling that occurs during pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus.

Chlorothiazide is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. High doses of thiazides can also suppress lactation by inducing diuresis and reducing the hormones needed for milk production.

Chlorothiazide is frequently used in pediatric medicine, particularly for children with heart failure or those who have developed fluid retention from other medications.

• Safety: It has been used safely in infants and children for decades.
• Monitoring: Children are more sensitive to fluid shifts. Close monitoring of weight and electrolytes is mandatory.
• Growth: There is no evidence that long-term use of Chlorothiazide affects the normal growth and development of children.

Clinical studies of Chlorothiazide did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. However, clinical experience has identified several concerns:

• Fall Risk: Increased urination and potential dizziness significantly increase the risk of falls and hip fractures in the elderly.
• Renal Clearance: Since the drug is excreted by the kidneys, and elderly patients are more likely to have decreased renal function, the risk of toxic reactions is higher.
• Polypharmacy: Elderly patients are often on multiple medications (like NSAIDs or Digoxin), increasing the complexity of drug interactions.

In patients with renal disease, thiazides may precipitate azotemia. Cumulative effects of the drug may develop in patients with impaired renal function. If progressive renal impairment becomes evident, as indicated by a rising nonprotein nitrogen or blood urea nitrogen (BUN), a careful reappraisal of therapy is necessary with consideration given to withholding or discontinuing diuretic therapy.

Thiazides should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma. Many clinicians prefer to use Chlorothiazide only in a hospital setting for patients with severe cirrhosis.

> Important: Special populations require individualized medical assessment and more frequent laboratory monitoring.

Chlorothiazide exerts its effect by interfering with the renal tubular mechanism of electrolyte reabsorption. The primary site of action is the Distal Convoluted Tubule (DCT). It specifically inhibits the Na+/Cl- cotransporter (NCC) on the luminal membrane of the epithelial cells. By blocking this transporter, Chlorothiazide increases the excretion of sodium and chloride in approximately equivalent amounts.

Natriuresis (sodium loss) is accompanied by a secondary loss of potassium and bicarbonate. It also reduces the glomerular filtration rate (GFR) slightly when initiated. A unique secondary effect of thiazides is the promotion of calcium reabsorption in the distal tubule, which is the opposite effect of loop diuretics (which increase calcium loss).

• Onset of Action: For oral administration, diuresis begins within 2 hours, peaks at 4 hours, and lasts 6 to 12 hours. For IV administration, onset is within 15 minutes, with a peak at 30 minutes.
• Antihypertensive Effect: The initial drop in blood pressure is due to a decrease in plasma volume and cardiac output. After several weeks of use, plasma volume returns toward normal, but peripheral vascular resistance remains decreased, maintaining the lower blood pressure.
• Tolerance: "Diuretic resistance" can occur with long-term use as the kidneys attempt to compensate by increasing sodium reabsorption in other parts of the nephron.

| Parameter | Value |

|---|---|

| Bioavailability | 9% - 25% (Oral) |

| Protein Binding | 20% - 80% (Albumin) |

| Half-life | 1.5 - 2.5 hours |

| Tmax (Time to peak) | 4 hours (Oral) |

| Metabolism | Not metabolized (Excreted unchanged) |

| Excretion | Renal (>95%) |

• Molecular Formula: C7H6ClN3O4S2
• Molecular Weight: 295.72 g/mol
• Solubility: Very slightly soluble in water; soluble in alkaline solutions (which is why the sodium salt is used for injection).
• Structure: It is a white or practically white crystalline powder. Chemically, it is 6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide.

Chlorothiazide is the prototypical member of the Thiazide Diuretic class. Related medications include Hydrochlorothiazide, Chlorthalidone (a thiazide-like diuretic), and Indapamide. It is classified under the ATC code C03AA04.